160 related articles for article (PubMed ID: 31643055)
1. ADC Analysis by Hydrophobic Interaction Chromatography.
Fleming R
Methods Mol Biol; 2020; 2078():147-161. PubMed ID: 31643055
[TBL] [Abstract][Full Text] [Related]
2. Hydrophobic interaction chromatography (HIC) method development and characterization of resolved drug-load variants in site-specifically conjugated pyrrolobenzodiazepine dimer-based antibody drug conjugates (PBD-ADCs).
Janaratne T; Wang XC; Becker C; Zhao Y; Leanna R; Pritts W
J Pharm Biomed Anal; 2020 Feb; 179():113027. PubMed ID: 31830625
[TBL] [Abstract][Full Text] [Related]
3. Two-Dimensional Liquid Chromatography Coupled to High-Resolution Mass Spectrometry for the Analysis of ADCs.
Chapel S; Rouvière F; Sarrut M; Heinisch S
Methods Mol Biol; 2020; 2078():163-185. PubMed ID: 31643056
[TBL] [Abstract][Full Text] [Related]
4. Online coupling of analytical hydrophobic interaction chromatography with native mass spectrometry for the characterization of monoclonal antibodies and related products.
Yan Y; Xing T; Wang S; Daly TJ; Li N
J Pharm Biomed Anal; 2020 Jul; 186():113313. PubMed ID: 32371326
[TBL] [Abstract][Full Text] [Related]
5. Purification of ADCs by Hydrophobic Interaction Chromatography.
Becker CL; Duffy RJ; Gandarilla J; Richter SM
Methods Mol Biol; 2020; 2078():273-290. PubMed ID: 31643064
[TBL] [Abstract][Full Text] [Related]
6. Drug-to-antibody ratio (DAR) and drug load distribution by hydrophobic interaction chromatography and reversed phase high-performance liquid chromatography.
Ouyang J
Methods Mol Biol; 2013; 1045():275-83. PubMed ID: 23913154
[TBL] [Abstract][Full Text] [Related]
7. [The Characterization of Drug-to-Antibody Ratio and Isoforms of ADCs Using LC and MS Technologies].
Iizuka R; Kotch F; Xu A; Porter T; Shion H; Birdsall R; Chen W
Yakugaku Zasshi; 2017; 137(5):525-528. PubMed ID: 28458283
[TBL] [Abstract][Full Text] [Related]
8. Innovative native MS methodologies for antibody drug conjugate characterization: High resolution native MS and IM-MS for average DAR and DAR distribution assessment.
Debaene F; Boeuf A; Wagner-Rousset E; Colas O; Ayoub D; Corvaïa N; Van Dorsselaer A; Beck A; Cianférani S
Anal Chem; 2014 Nov; 86(21):10674-83. PubMed ID: 25270580
[TBL] [Abstract][Full Text] [Related]
9. Analysis of antibody-drug conjugates by comprehensive on-line two-dimensional hydrophobic interaction chromatography x reversed phase liquid chromatography hyphenated to high resolution mass spectrometry. I - Optimization of separation conditions.
Sarrut M; Corgier A; Fekete S; Guillarme D; Lascoux D; Janin-Bussat MC; Beck A; Heinisch S
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Oct; 1032():103-111. PubMed ID: 27426266
[TBL] [Abstract][Full Text] [Related]
10. Impact of drug-linker on method selection for analytical characterization and purification of antibody-drug conjugates.
Santora LC; Hobson AD; Wang L; Wu KX
Anal Methods; 2024 Jun; 16(22):3492-3503. PubMed ID: 38770747
[TBL] [Abstract][Full Text] [Related]
11. Native Reversed-Phase Liquid Chromatography: A Technique for LCMS of Intact Antibody-Drug Conjugates.
Chen TH; Yang Y; Zhang Z; Fu C; Zhang Q; Williams JD; Wirth MJ
Anal Chem; 2019 Feb; 91(4):2805-2812. PubMed ID: 30661356
[TBL] [Abstract][Full Text] [Related]
12. Optimization of non-linear gradient in hydrophobic interaction chromatography for the analytical characterization of antibody-drug conjugates.
Bobály B; Randazzo GM; Rudaz S; Guillarme D; Fekete S
J Chromatogr A; 2017 Jan; 1481():82-91. PubMed ID: 28017562
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of hydrophobic-interaction chromatography resins for purification of antibody-drug conjugates using a mimetic model with adjustable hydrophobicity.
Müller E; Sevilla M; Endres P
J Sep Sci; 2020 Jun; 43(12):2255-2263. PubMed ID: 32160397
[TBL] [Abstract][Full Text] [Related]
14. Modeling of hydrophobic interaction chromatography for the separation of antibody-drug conjugates and its application towards quality by design.
Andris S; Hubbuch J
J Biotechnol; 2020 Jun; 317():48-58. PubMed ID: 32361022
[TBL] [Abstract][Full Text] [Related]
15. An Online Four-Dimensional HIC×SEC-IM×MS Methodology for Proof-of-Concept Characterization of Antibody Drug Conjugates.
Ehkirch A; D'Atri V; Rouviere F; Hernandez-Alba O; Goyon A; Colas O; Sarrut M; Beck A; Guillarme D; Heinisch S; Cianferani S
Anal Chem; 2018 Feb; 90(3):1578-1586. PubMed ID: 29260862
[TBL] [Abstract][Full Text] [Related]
16. Analysis of ADCs by Native Mass Spectrometry.
Hernandez-Alba O; Ehkirch A; Beck A; Cianférani S
Methods Mol Biol; 2020; 2078():197-211. PubMed ID: 31643058
[TBL] [Abstract][Full Text] [Related]
17. Characterization of drug load variants in a thiol linked antibody-drug conjugate using multidimensional chromatography.
Gilroy JJ; Eakin CM
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Aug; 1060():182-189. PubMed ID: 28622622
[TBL] [Abstract][Full Text] [Related]
18. Impact of linker-drug on ion exchange chromatography separation of antibody-drug conjugates.
Zhang Z; Zhou S; Han L; Zhang Q; Pritts WA
MAbs; 2019; 11(6):1113-1121. PubMed ID: 31238787
[TBL] [Abstract][Full Text] [Related]
19. Practical method development for the separation of monoclonal antibodies and antibody-drug-conjugate species in hydrophobic interaction chromatography, part 1: optimization of the mobile phase.
Rodriguez-Aller M; Guillarme D; Beck A; Fekete S
J Pharm Biomed Anal; 2016 Jan; 118():393-403. PubMed ID: 26609679
[TBL] [Abstract][Full Text] [Related]
20. Streamlined Characterization of an Antibody-Drug Conjugate by Two-Dimensional and Four-Dimensional Liquid Chromatography/Mass Spectrometry.
Goyon A; Kim M; Dai L; Cornell C; Jacobson F; Guillarme D; Stella C
Anal Chem; 2019 Dec; 91(23):14896-14903. PubMed ID: 31621311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
